Mazabraud Yann — SEC Form 4 filings

SEC reporting owner CIK 1774702. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-02-13 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RHYTHM PHARMACEUTICALS, INC. (RYTM)EVP, Head of International1514 legs · 175,046 sh · $12,760,40835

Form 4 filings — Mazabraud Yann

FiledFormIssuerReported transactionsSource
2026-08-144RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 46,625 @ $6.80 · Sale (S): 2,300 @ $111.80 · Sale (S): 1,000 @ $112.86 · Sale (S): 3,605 @ $114.70 · Sale (S): 14,568 @ $115.43 · Sale (S): 18,208 @ $116.49 · +2 moreEDGAR
2026-04-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 12,875 · Option exercise (M): 10,375 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2026-03-044RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2026-02-184RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 10,000 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-02-134RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 23,350 (derivative) @ $0EDGAR
2026-02-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 5,500 · Option exercise (M): 5,500 (derivative) @ $0EDGAR
2025-05-014RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 6,745 @ $65.08EDGAR
2025-04-164RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 10,375 · Option exercise (M): 11,405 · Option exercise (M): 10,375 (derivative) @ $0 · Option exercise (M): 8,905 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2025-04-104RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 8,438 @ $60.37 · Sale (S): 9,312 @ $61.54EDGAR
2025-03-184RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 75,000 @ $22.28 · Sale (S): 19,197 @ $50.79 · Sale (S): 55,803 @ $51.72 · Option exercise (M): 75,000 (derivative) @ $0EDGAR
2025-02-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 5,500 · Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Option exercise (M): 5,500 (derivative) @ $0EDGAR
2024-04-164RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 10,375 · Option exercise (M): 10,375 (derivative) @ $0 · Disposition to issuer (D): 2,031 (derivative) @ $0 · Disposition to issuer (D): 6,874 (derivative) @ $0 · Grant/award (A): 8,905 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2024-03-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 16,000 @ $39.22EDGAR
2024-02-214RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 33,750 @ $0 · Grant/award (A): 22,000 (derivative) @ $0 · Grant/award (A): 67,000 (derivative) @ $0EDGAR
2024-02-134RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 3,438 · Option exercise (M): 2,031 · Sale (S): 1,594 @ $51.38 · Sale (S): 957 @ $49.84 · Option exercise (M): 3,438 (derivative) @ $0 · Option exercise (M): 2,031 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1774702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →